Results 251 to 260 of about 92,469 (306)

The methyltransferase METTL16 in digestive system cancers: functions and mechanisms. [PDF]

Front Oncol
Li J, Bao Y, Yao F, Wu Q.
europepmc   +1 more source

Clinically aggressive early-onset pancreatic ductal adenocarcinoma with KRAS wild-type status: A case report. [PDF]

Biomed Rep
Avendaño ME, San Martin Abello C, Gómez-Valenzuela F, Silva I, Retamal IN, García-Bloj B, De Mayo Glaser T, Muñoz-Medel M, Gómez A, Sánchez C, Pinto F, Aravena P, Sabioncello AC, Garrido Villanueva M, Sigler Chávez F, Corvalán I, Barrios H, Sáez MA, Erpel JM, Manque PA, Rios JA, Godoy JA, Garrido M.   +22 more
europepmc   +1 more source

Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC. [PDF]

J Transl Med
Liu M, Seier K, Gonen M, Sigel C, Jung J, Blair AB, Howell TC, Reidy-Lagunes D, Lidsky ME, Allen PJ, Blazer Iii DG, Zani S, Wei AC, Drebin JA, Balachandran V, D'Angelica M, Soares KC, Kingham TP, Jarnagin WR.   +18 more
europepmc   +1 more source

Prognostic Value of Tumor-Infiltrating Lymphocytes in Resected Pancreatic Ductal Adenocarcinoma: A Single-Center Retrospective Australian Study. [PDF]

Cureus
Siribaddana H, Jayaratne P, Gounden S, Whittaker D, Burge M, Tran K, Hoff JW, Tee CL, Chandrasegaram MD.   +8 more
europepmc   +1 more source

Centrosome abnormalities in pancreatic ductal carcinoma

Centrosome abnormalities in pancreatic ductal carcinoma
openaire  

Some of the next articles are maybe not open access.

Related searches:

Human microbiota colonization and pancreatic ductal carcinoma

Critical Reviews in Microbiology, 2022
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high mortality rate and a poor prognosis. The human microbiota has been confirmed to participate in oncogenesis and may influence the treatment response to both chemotherapy and immunotherapy.
Yuan, Fang, Gang, Yang, Jinshou, Yang, Jie, Ren, Lei, You, Yupei, Zhao   +5 more
openaire   +2 more sources

Adjuvant treatment for pancreatic ductal carcinoma

Clinical and Translational Oncology, 2017
Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a very poor prognosis. Most of the patients are diagnosed in advanced stages of the disease, and 5-year survival rates in these patients remains
T. Macarulla, T. Fernández, M. E. Gallardo, O. Hernando, A. M. López, M. Hidalgo   +5 more
openaire   +2 more sources

Hematogenous Metastases of Pancreatic Ductal Carcinoma

Pancreas, 1995
To investigate the heterogeneity of hematogenous metastases of pancreatic ductal carcinoma, we investigated carcinomatous spread in 130 autopsy cases. Hepatic metastases occurred most frequently, in 81 cases (62%), which may be explained by the fact that all veins draining the pancreas flow into the portal system.
T, Kamisawa, T, Isawa, M, Koike, K, Tsuruta, A, Okamoto   +4 more
openaire   +2 more sources

Pancreatic ductal cell carcinoma producing pancreatic elastase 1

Journal of Surgical Oncology, 1993
AbstractThe elevation of plasma pancreatic elastase 1 in patients with pancreatic cancer is caused by concomitant pancreatitis. There is no report that pancreatic ductal cell carcinoma tissue itself produced elastase 1. A 54‐year‐old woman underwent total pancreatectomy for pancreatic ductal cell carcinoma.
K, Iwase, M, Miyata, T, Yamaguchi, T, Kawaguchi, Y, Tanaka, H, Matsuda   +5 more
openaire   +2 more sources